C L Clarke

Author PubWeight™ 50.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Physiological action of progesterone in target tissues. Endocr Rev 1997 2.73
2 Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 2002 1.54
3 Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1999 1.29
4 Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 2001 1.22
5 Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 1995 1.22
6 Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J Neurosci 1995 1.21
7 Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther 2007 1.18
8 The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes Chromosomes Cancer 2000 1.11
9 Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod 2000 1.11
10 Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res 2000 1.11
11 Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Oncogene 2006 1.10
12 Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 1992 1.10
13 Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 2001 1.08
14 Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators. J Mol Endocrinol 1999 1.01
15 Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 1993 0.97
16 Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse 1999 0.97
17 Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet Cytogenet 1998 0.96
18 Expression and hormonal regulation of the Sox4 gene in mouse female reproductive tissues. Biol Reprod 1999 0.96
19 Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 1988 0.95
20 Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Mol Endocrinol 1999 0.94
21 Progesterone receptor isoforms in normal and malignant breast. Ernst Schering Found Symp Proc 2007 0.93
22 Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women. Br J Cancer 1999 0.92
23 Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Mol Cell Endocrinol 2012 0.91
24 Hearing the voices of children with chronic illness. J Adv Nurs 2000 0.91
25 Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 1990 0.91
26 Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin. J Neurosci 1998 0.91
27 Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 1987 0.91
28 Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells. J Biol Chem 1995 0.90
29 Induction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture. J Clin Endocrinol Metab 1982 0.88
30 Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 1988 0.87
31 Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol Endocrinol 1989 0.87
32 Progesterone receptor A and B protein expression in human breast cancer. J Steroid Biochem Mol Biol 1996 0.86
33 Ultrastructural localization of sorcin, a 22 kDa calcium binding protein, in the rat caudate-putamen nucleus: association with ryanodine receptors and intracellular calcium release. J Comp Neurol 1997 0.84
34 Tumour banks: providing human tissue for cancer research. Med J Aust 2001 0.84
35 Solubilization and characterization of a lactogenic receptor from human placental chorion membranes. J Cell Biochem 1990 0.84
36 The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5. Mol Endocrinol 2010 0.83
37 N-methyl-D-aspartate receptor 1 in the caudate-putamen nucleus: ultrastructural localization and co-expression with sorcin, a 22,000 mol. wt calcium binding protein. Neuroscience 1999 0.83
38 Characterization of a truncated progesterone receptor protein in breast tumors. J Clin Endocrinol Metab 1998 0.82
39 Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Res Treat 2014 0.82
40 Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. Cancer Lett 1992 0.82
41 Immunohistochemical detection of progesterone receptors in archival breast cancer. Biotech Histochem 1998 0.81
42 Coexpression of alternatively spliced estrogen and progesterone receptor transcripts in human breast cancer. J Clin Endocrinol Metab 1999 0.81
43 Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells. Int J Cancer 1992 0.80
44 Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content. Eur J Cancer 1997 0.79
45 Progestin-mediated changes in progesterone receptor forms in the normal human endometrium. Endocrinology 1988 0.79
46 Expression of the oestrogen responsive protein pS2 in human breast cancer. Histol Histopathol 1999 0.78
47 Progesterone receptor structure and protease activity in primary human endometrial carcinoma. Cancer Res 1988 0.78
48 Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts. Breast Cancer Res Treat 2004 0.78
49 Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels. J Mol Endocrinol 2003 0.78
50 Histopathologic indicators of breast cancer biology: insights from population mammographic screening. Br J Cancer 2005 0.77
51 Ultrastructural localization of delta-opioid receptor and Met5-enkephalin immunoreactivity in rat insular cortex. Brain Res 1995 0.77
52 Hormones and cancer: new insights, new challenges. Trends Endocrinol Metab 2001 0.76
53 Nursing older people: constructing need and care. Nurs Inq 1999 0.75
54 Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma. J Steroid Biochem 1987 0.75
55 A polyclonal antiserum against the rabbit progesterone receptor recognizes the human receptor: biochemical characterization. Cell Biochem Funct 1989 0.75
56 A polyclonal antiserum against the rabbit progesterone receptor recognizes the human receptor: immunohistochemical localization in rabbit and human uterus. Cell Biochem Funct 1989 0.75
57 Epidermal growth factor receptor expression on human breast luminal and basal cells in vitro. Epithelial Cell Biol 1995 0.75
58 Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma. Cancer Res 1985 0.75
59 The effect of progestins on prolactin receptor gene transcription in human breast cancer cells. DNA Cell Biol 1992 0.75
60 Association of hereditary angioedema and hereditary breast cancer. Cancer Genet Cytogenet 1997 0.75
61 Our aging society. J Tenn Dent Assoc 1983 0.75
62 Quality assurance in proprietary medicines. Med Serv J Can 1967 0.75
63 Steroid receptors, transcription factors, and gene expression. AACR special conference in cancer research. Cancer Res 1990 0.75
64 Sex steroid receptors in normal and malignant endometrium. Ann Pathol 1986 0.75
65 Effect of photoaffinity labeling on rabbit uterine progesterone receptor. Anal Biochem 1986 0.75
66 Differential distribution of estrogen and progesterone receptors in rabbit uterus detected by dual immunofluorescence. Endocrinology 1989 0.75